Author
Listed:
- Helen R Griffin
- Darroch H Hall
- Ana Topf
- James Eden
- A Graham Stuart
- Jonathan Parsons
- Ian Peart
- John E Deanfield
- John O'Sullivan
- Sonya V Babu-Narayan
- Michael A Gatzoulis
- Frances A Bu'Lock
- Shoumo Bhattacharya
- Jamie Bentham
- Martin Farrall
- Javier Granados Riveron
- J David Brook
- John Burn
- Heather J Cordell
- Judith A Goodship
- Bernard Keavney
Abstract
Several previous studies have investigated the role of common promoter variants in the vascular endothelial growth factor (VEGF) gene in causing congenital cardiovascular malformation (CVM). However, results have been discrepant between studies and no study to date has comprehensively characterised variation throughout the gene. We genotyped 771 CVM cases, of whom 595 had the outflow tract malformation Tetralogy of Fallot (TOF), and carried out TDT and case-control analyses using haplotype-tagging SNPs in VEGF. We carried out a meta-analysis of previous case-control or family-based studies that had typed VEGF promoter SNPs, which included an additional 570 CVM cases. To identify rare variants potentially causative of CVM, we carried out mutation screening in all VEGF exons and splice sites in 93 TOF cases. There was no significant effect of any VEGF haplotype-tagging SNP on the risk of CVM in our analyses of 771 probands. When the results of this and all previous studies were combined, there was no significant effect of the VEGF promoter SNPs rs699947 (OR 1.05 [95% CI 0.95–1.17]); rs1570360 (OR 1.17 [95% CI 0.99–1.26]); and rs2010963 (OR 1.04 [95% CI 0.93–1.16]) on the risk of CVM in 1341 cases. Mutation screening of 93 TOF cases revealed no VEGF coding sequence variants and no changes at splice consensus sequences. Genetic variation in VEGF appears to play a small role, if any, in outflow tract CVM susceptibility.
Suggested Citation
Helen R Griffin & Darroch H Hall & Ana Topf & James Eden & A Graham Stuart & Jonathan Parsons & Ian Peart & John E Deanfield & John O'Sullivan & Sonya V Babu-Narayan & Michael A Gatzoulis & Frances A , 2009.
"Genetic Variation in VEGF Does Not Contribute Significantly to the Risk of Congenital Cardiovascular Malformation,"
PLOS ONE, Public Library of Science, vol. 4(3), pages 1-7, March.
Handle:
RePEc:plo:pone00:0004978
DOI: 10.1371/journal.pone.0004978
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:plo:pone00:0004978. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: plosone (email available below). General contact details of provider: https://journals.plos.org/plosone/ .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.